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54 Poster Session-ITaste disorders are rarely discussed in the literature, it’s a significant
and prevalent problem reported by HSCT patients. The etiology of
taste disorders is multifactorial, however, the understanding of this
complain in this special group of patient should be better investi-
gated. The aim of this study was to evaluate prospectively, taste per-
ception, salivary flow rate and oral conditions in three different
groups of 61 adults patients submitted to allogeneic myeloablative
and non-myeloablative HSCT considering post-transplant timing.
Patients were classified into Group I(n5 20), up to 150 days, Group
II(n 5 20), between 151–1094 days, and Group III(n 5 21), above
1094 days. Taste acuity was measured by the taste thresholds for
the four basic tastes using 5ml of 4 solutions, in 3 concentration-
s(mol/L): NaCl(0.01;0.50;1.00), sucrose(0.01;0.50;1.00), citric
acid(0.32;0.0158;0.032), caffeine(1.988  10-5;0.644  10-2;1.277
 10–2). Patients considered flavors and their intensity as high,
medium and low. Unstimulated saliva was collected into separate
pre-weight plastic test glass and salivary flow rates were determinate
in ml/m. Oral cavity was examined in order to verify the presence of
GVHD, the presence of pain and oral infections. From those 61
patients, 31 presented cGVHD(Group I 5 3; Group II 5 14 and
Group III 5 14). In general, the sour and bitter perception was
not different between the 3 groups. The intensity of the sweet solu-
tion in the high and low concentrations were a challenging to be de-
termined for those patients(p5 0.04 and p5 0.05 respectively). For
the medium salty concentration and high sucrose concentration the
tastes were difficult to be determined only by the Group I(p 5 0.08
and p5 0.07 respectively). The saliva flow rate was diminished in 10/
61 patients in all periods(1.36 (0.01–1.3 5- SD 0.296) and hyposali-
vation was more intense in the Groups II/III(p5 0.007). There was
no correlation of taste dysfunction with oral cGVHD lesions. The
results indicate that, despite the hyposalivation, taste alterations
were only observed for the sweet and salty tastes even in patients
up to 3 years post-HSCT. These results may indicate that taste alter-
ations post-HSCT are not correlated to oral cGVHD and to hypo-
salivation but may be considered as an individual response of the
HSCT.142
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Several studies have begun to examine the relationship between
psychosocial variables and outcome in hematopoietic stem cell trans-
plantation (HSCT). Previous studies have also looked at the rela-
tionship between the Hematopoietic Cell Transplantation
Comorbidity Index (HCT-CI) and overall survival in HSCT which
demonstrated a negative relationship between HCT-CI and overall
survival. In this study, data was collected on 128 patients undergoing
HSCT. Based on the patient’s TERS score, each patient was strati-
fied into one of two groups (low/moderate risk (n5 96) vs. high risk
(n 5 32)) based on their predicted psychosocial risk for problems
during transplant. Patients were also stratified into two categories
on the HCT-CI (low (n5 102) vs. high (n5 26)) based on the num-
ber of comorbid features present pre-transplant. Patients were also
grouped into disease risk categories as classified by the CIBMTR
criteria. Only the TERS was found to be a significant predictor of
utilization of resources (length of hospitalization) between low/mod-
erate risk (26 days) versus high risk (40 days) patients (p\.02). The
HCT-CI (p 5 .014) and CIBMTR disease risk status (p 5 .02)
were found to be significantly correlated with overall survival. Alone,
the TERS showed a similar trend but did not appear to have a signif-
icant impact on overall survival. Those patients who scored lowest on
all three measures (TERS, HCT-CI and CIBMTR disease risk) had
the best overall survival rate, nearing 75% survival at 2 years post
HSCT. One would conclude that although psychosocial factors im-
pact the utilization of resources, well equipped transplant centers can
provide a relatively safe method for high risk psychosocial patients to
undergo HSCT. These results reinforce the impact of the HCT-CIand disease risk on transplant outcome previously found at other
large transplant centers.143
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Advancements in the field of hematopoietic cell transplantation
(HCT) has led to an increasing number of long-term HCT survi-
vors. For selected survivors with severe organ dysfunction, solid or-
gan transplantation (SOT) may offer the best chance for better
quality of life and extended survival. However, SOT following
HCT has not been well described. We report a single institution
experience of SOT in 11 HCT recipients. Transplanted organs
included kidney (N 5 7), lung (N 5 2), liver (N 5 2) and heart
(N 5 1). Age at HCT ranged from 2 to 59 years. All patients were
100% donor engrafted and in complete remission from their under-
lying malignancy at the time of SOT. Among recipients of allogeneic
HCT, 5/9 had a history of chronic graft-versus-host disease
(GVHD); only three patients had active GVHD at the time of
SOT. Median time between HCT and SOT was 7.4 years (range
1.2–15.9 years). Four patients have died, one patient received his
SOT at another institution and was lost for followup, while six
patients are alive with a median followup of 2 years (range 0.5 – 6
years). Among the 10 patients with post-SOT followup information,
9 had normal function of the transplanted solid organ at the time of
last contact or death. Two patients developed cytomegalovirus reac-
tivation, one patient developed post transplantation lymphoprolifer-
ative disorder, and one patient developed second malignancy after
SOT. SOT is feasible in selected HCT recipients with organ failure
and is associated with favorable long-term survival and graft func-
tion. More research is needed to further delineate the subset of
HCT survivors who will benefit the most with SOT with the least
risk of significant complications.
Patients’ characteristics and outcome
Patient Organ & Time b/w Follow-upage/sex HCT type Diagnosis Indication HCT & SOT after SOT27 F Autologous Hodgkin’s
lymphomaLung,
Interstitial
fibrosis7.4 yrs 2 yrs, alive56 M Autologous Myeloma Cadaveric
kidney,
ESRD2.9 yrs 2 yrs, alive37 M Allo Sib Aplastic
anemiaSibling
kidney,
ESRD5.6 yrs 8.9 yrs,
dead
(ischemic
cardiomyopathy)46 M Allo Sib Mantle
cell
lymphomaSibling
kidney,
ESRD7.4 yrs 2.2 yrs, dead
(metastatic
squamous
cell cancer
of tongue)59 M Allo Sib CML Sibling
kidney,
ESRD15.9 yrs 5.9 yrs, alive41 M Allo MUD CML Combined
heart and
cadaveric kidney,
Cardiomyopathy
and ESRD12.3 yrs 0.5 yrs, alive2 F Allo Sib Neurob
lastomaSibling kidney,
ESRD9.3 yrs 6 yrs, alive8 F Allo Sib AML Cadaveric liver,
HCV cirrhosis6.5 yrs 1 mo, dead
(aspergillosis)12 M Allo Sib Aplastic
anemiaCadaveric liver,
fulminant
hepatitis9.8 yrs 1.5 yrs, alive(Continued )
